Wide Ranks

AEON

AEON Biopharma, Inc.

0.5353

Top Statistics
Market Cap 21 M Forward PE -0.7758 Revenue Growth 0.00 %
Current Ratio 0.39 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -0.7510 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 3 M Total Cash Per Share 0.0870 Total Debt 14 M
Total Debt To Equity Current Ratio 0.39 Book Value Per Share -4.12
All Measures
Short Ratio 160.00 % Message Board Id finmb_247856902 Shares Short Prior Month 153113
City Irvine Uuid 818fa4c7-1301-356c-8781-c235768c4fd3 Previous Close 0.5493
First Trade Date Epoch Utc 1 B Book Value -4.12 Beta 0.3970
Total Debt 14 M Volume 103065 Fifty Two Week Low 0.5210
Total Cash Per Share 0.0870 Shares Short Previous Month Date 1 B Target Median Price 5.00
Max Age 86400 Sand P52 Week Change 0.3133 Target Mean Price 5.00
Net Income To Common -305520000 Ask 0.5531 Short Percent Of Float 0.0072
Implied Shares Outstanding 39 M Last Fiscal Year End 1 B Trailing Peg Ratio None
Average Daily Volume10 Day 131990 Average Volume10days 131990 Total Cash 3 M
Next Fiscal Year End 1 B Held Percent Insiders 0.3623 Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 0.5493
Target Low Price 5.00 Gmt Off Set Milliseconds -18000000 Fifty Day Average 0.8838
Open 0.5594 Free Cashflow -24595624 State CA
Dividend Yield 0.00 % Return On Assets -5.98 Time Zone Short Name EST
Trailing Eps -0.1100 Day Low 0.5353 Address1 5 Park Plaza
Shares Outstanding 39 M Price Hint 4 Target High Price 5.00
Website https://www.aeonbiopharma.com 52 Week Change -0.9060 Average Volume 143381
Forward Eps -0.6900 Recommendation Key none Compensation As Of Epoch Date 1 B
Quick Ratio 33.00 % Is_sp_500 False Regular Market Day High 0.5685
Profit Margins 0.00 % Fifty Two Week High 17.17 Day High 0.5685
Shares Short 164257 Regular Market Open 0.5594 Industry Key biotechnology
Bid 0.5353 Earnings Growth 0.00 % Revenue Growth 0.00 %
Shares Percent Shares Out 0.0041 Operating Cashflow -43398000 Currency USD
Time Zone Full Name America/New_York Market Cap 21 M Is_nasdaq_100 False
Zip 92614 Quote Type EQUITY Industry Biotechnology
Long Name AEON Biopharma, Inc. Regular Market Day Low 0.5353 Held Percent Institutions 0.3314
Current Price 0.5353 Address2 Suite 1750 Enterprise To Ebitda -0.7510
Financial Currency USD Current Ratio 0.39 Industry Disp Biotechnology
Number Of Analyst Opinions 1 Country United States Float Shares 17 M
Two Hundred Day Average 3.50 Enterprise Value 32 M Forward PE -0.7758
Regular Market Volume 103065 Ebitda -43861000 Exchange ASE
Go to Yahoo Finance Go to Seeking Alpha 
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins.

It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and posttraumatic stress disorder.

The company is based in Irvine, California.